ReAlta Life Sciences Inc., a clinical-stage biopharmaceutical company, has appointed Ellen Lubman, MBA as Chief Business Officer. In this role, Lubman will oversee business development, capital formation, and corporate strategy. “Ellen is a highly respected executive with a strong track record of building partnerships, raising capital, and developing successful corporate strategies for biotech and pharmaceutical companies,” said David Marek, CEO of ReAlta. “Her deep strategic and transactiona...